Weiming Yan

7.3k total citations
112 papers, 2.2k citations indexed

About

Weiming Yan is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Weiming Yan has authored 112 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 30 papers in Molecular Biology and 29 papers in Immunology. Recurrent topics in Weiming Yan's work include Hepatitis B Virus Studies (30 papers), Liver Disease Diagnosis and Treatment (21 papers) and Hepatitis C virus research (19 papers). Weiming Yan is often cited by papers focused on Hepatitis B Virus Studies (30 papers), Liver Disease Diagnosis and Treatment (21 papers) and Hepatitis C virus research (19 papers). Weiming Yan collaborates with scholars based in China, United States and Canada. Weiming Yan's co-authors include Qin Ning, Meifang Han, Xiaoping Luo, Zeguang Wu, Tao Chen, Xiaojing Wang, Hongwu Wang, Di Wu, Xi Dong and Sheng Guo and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Immunology.

In The Last Decade

Weiming Yan

102 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiming Yan China 26 719 680 492 449 236 112 2.2k
Lihua Zhu China 25 963 1.3× 1.1k 1.7× 440 0.9× 338 0.8× 121 0.5× 46 2.6k
Wei Cai China 26 583 0.8× 750 1.1× 251 0.5× 482 1.1× 73 0.3× 90 1.9k
Shunhei Yamashina Japan 29 902 1.3× 1.7k 2.4× 449 0.9× 588 1.3× 86 0.4× 70 3.2k
Zongfang Li China 29 873 1.2× 436 0.6× 429 0.9× 275 0.6× 61 0.3× 96 2.3k
Justine Newson United Kingdom 20 573 0.8× 373 0.5× 775 1.6× 178 0.4× 67 0.3× 21 2.0k
Koji Yano Japan 27 411 0.6× 629 0.9× 512 1.0× 535 1.2× 61 0.3× 77 2.2k
Fengyun Xu United States 23 634 0.9× 493 0.7× 213 0.4× 400 0.9× 43 0.2× 32 2.4k
Masakazu Kobayashi Japan 28 828 1.2× 497 0.7× 282 0.6× 375 0.8× 62 0.3× 120 2.7k
Xiuyan Yang China 29 970 1.3× 253 0.4× 471 1.0× 142 0.3× 80 0.3× 133 2.7k

Countries citing papers authored by Weiming Yan

Since Specialization
Citations

This map shows the geographic impact of Weiming Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiming Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiming Yan more than expected).

Fields of papers citing papers by Weiming Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiming Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiming Yan. The network helps show where Weiming Yan may publish in the future.

Co-authorship network of co-authors of Weiming Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Weiming Yan. A scholar is included among the top collaborators of Weiming Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiming Yan. Weiming Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
You, Jie, Fei Huang, Peng Wang, et al.. (2025). High‐Throughput Viral Integration Detection Reveals Baseline Breakpoints Burden Associated With HBsAg Seroclearance. Alimentary Pharmacology & Therapeutics. 62(9). 887–900.
2.
3.
Chen, Chengming, Huan Zhang, Yanyan Lan, et al.. (2024). Statins as a risk factor for diabetic retinopathy: a Mendelian randomization and cross-sectional observational study. Journal of Translational Medicine. 22(1). 298–298. 12 indexed citations
4.
Yan, Weiming, et al.. (2024). Unlocking the antiviral potential of rosmarinic acid against chikungunya virus via IL-17 signaling pathway. Frontiers in Cellular and Infection Microbiology. 14. 1396279–1396279. 3 indexed citations
5.
Hu, Danqing, Peng Wang, Xiaojing Wang, et al.. (2024). The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosis. Heliyon. 10(7). e28653–e28653. 3 indexed citations
6.
Wan, Xiaoyang, Zhe Shen, Zhongwei Zhang, et al.. (2023). Fibrinogen-like protein 2 regulates macrophage glycolytic reprogramming by directly targeting PKM2 and exacerbates alcoholic liver injury. International Immunopharmacology. 124(Pt B). 110957–110957. 6 indexed citations
7.
Tao, Ran, Wei Yuan, Fang Xiao, et al.. (2023). Fibrinogen-like protein 2 promotes proinflammatory macrophage polarization and mitochondrial dysfunction in liver fibrosis. International Immunopharmacology. 117. 109631–109631. 11 indexed citations
8.
Yan, Weiming, Huan Li, Pei Xiang, et al.. (2023). Hyperspectral anomaly detection based on local contrast estimation and sub-block background estimation. Infrared Physics & Technology. 135. 104966–104966. 4 indexed citations
9.
Fang, Cong, Weiming Yan, Zhiyong Dou, et al.. (2023). Long‐term SARS‐CoV‐2 neutralizing antibody level prediction using multimodal deep learning: A prospective cohort study on longitudinal data in Wuhan, China. Journal of Medical Virology. 95(8). e29036–e29036. 4 indexed citations
10.
Zhou, Wei, et al.. (2019). <p>LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α</p>. Clinical Interventions in Aging. Volume 14. 1663–1669. 29 indexed citations
11.
Long, Pan, Weiming Yan, Qianli Zhang, et al.. (2019). Protective effects of hydrogen gas in a rat model of branch retinal vein occlusion via decreasing VEGF-α expression. BMC Ophthalmology. 19(1). 112–112. 12 indexed citations
12.
Wu, Di, et al.. (2018). γδ T Cells Contribute to the Outcome of Murine Fulminant Viral Hepatitis via Effector Cytokines TNF-α and IFN-γ. Current Medical Science. 38(4). 648–655. 8 indexed citations
13.
Li, Jialin, Bo Diao, Sheng Guo, et al.. (2017). VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism. Nature Communications. 8(1). 1322–1322. 125 indexed citations
14.
Yan, Weiming, et al.. (2017). A kind of rd1 mouse in C57BL/6J mice from crossing with a mutated Kunming mouse. Gene. 607. 9–15. 11 indexed citations
15.
Chen, Tao, Lin Zhu, Lin Ding, et al.. (2017). Functional restoration of CD56bright NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B. Hepatology International. 11(5). 419–428. 15 indexed citations
16.
Yan, Xiaodong, Weiming Yan, Tao Chen, et al.. (2016). Ginsenoside Rd promotes non-amyloidogenic pathway of amyloid precursor protein processing by regulating phosphorylation of estrogen receptor alpha. Life Sciences. 168. 16–23. 39 indexed citations
17.
Liu, Yanling, Sanpeng Xu, Fei Xiao, et al.. (2010). The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway. Biochemical and Biophysical Research Communications. 396(2). 555–561. 32 indexed citations
18.
Wu, Zeguang, Meifang Han, Tao Chen, Weiming Yan, & Qin Ning. (2010). Acute liver failure: mechanisms of immune-mediated liver injury. Liver International. 30(6). 782–794. 231 indexed citations
19.
Wu, Zhourui, Weiming Yan, Wei Guo, et al.. (2010). Telbivudine preserves Th1 cytokine response and down regulates PD-L1 in MHV-3–induced viral hepatitis model. International Journal of Infectious Diseases. 14. e340–e340. 1 indexed citations
20.
Su, Kai, Fang Chen, Weiming Yan, et al.. (2008). Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-γ. World Journal of Gastroenterology. 14(39). 5980–5980. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lihua Zhu Breakdown of academic impact, for papers by Wei Cai Breakdown of academic impact, for papers by Shunhei Yamashina Breakdown of academic impact, for papers by Zongfang Li Breakdown of academic impact, for papers by Justine Newson Breakdown of academic impact, for papers by Koji Yano Breakdown of academic impact, for papers by Fengyun Xu Breakdown of academic impact, for papers by Masakazu Kobayashi Breakdown of academic impact, for papers by Xiuyan Yang
Rankless by CCL
2026